Case Report: Iptacopan combined with intensive immunosuppressive therapy in an older adult patient with severe aplastic anemia and paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hemolytic disorder. Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a standard of care as frontline treatment if a donor is available in younger patients with SAA regardless the presence of a PNH clone. However, older adult patients with SAA face high risks of infection and bleeding, poor treatment tolerance, and suboptimal overall survival after transplantation. Current guidelines recommend intensive immunosuppressive therapy (IST) as the frontline approach for older adult SAA. Here, we report a case of an older adult patient with SAA and PNH who received IST combined with iptacopan, resulting in significant improvement in both disease status and quality of life.
Authors
- 师锦宁
- Yongchao Ma
- Yuemin Gong (ORCID: https://orcid.org/0009-0005-7654-392X)
- Guangsheng He
- Yawen Zhang
- Chengtao Qin
- Ting Zhang
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Jiangning Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fimmu.2026.1770630
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00